How to cite this article: Peng, Z. et al. Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway. Here, TP53 is linked to breast carcinoma.